A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
about
Analysis of RAS oncogene mutations in human lymphoid malignanciesMutational analyses of the AML1 gene in patients with myelodysplastic syndromeEpstein-Barr virus associated B-cell lymphoma of brain developing in myelodysplastic syndrome with c-kit mutation (Try-557 -->stop).Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.Transforming genes in chronic myelogenous leukemia.Leukemia relapse reconsidered from the molecular aspect.Neoplasms associated with germline and somatic NF1 gene mutationsOncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation?RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.Role of proto-oncogene activation in carcinogenesis.An Update on the Biology of RAS/RAF Mutations in Colorectal Cancer.The molecular basis of myeloid malignancies.Study of p53 in elderly patients with myelodysplastic syndromes by immunohistochemistry and DNA analysisK-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovarySuppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (IAP) into the interleukin 3 gene.Transgenic mice carrying the mouse mammary tumor virus ras fusion gene: distinct effects in various tissues.Update on genetic and molecular markers associated with myelodysplastic syndromes.MicroRNAs in the midst of myeloid signal transduction.Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes.Multistep tumorigenesis in peripheral T cell lymphoma.Ras genes and acute myeloid leukaemia.Transgenic mice as future tools in risk assessment.Oncogenicity of human N-ras oncogene and proto-oncogene introduced into retroviral vectors.Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.Expression of the DCC gene in human hematological malignancies.Clonality in myelodysplastic syndromes.A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production.Application of long-term bone marrow cultures for studying the leukemic transformation of myelodysplastic syndromes.The SKM-1 leukemic cell line established from a patient with progression to myelomonocytic leukemia in myelodysplastic syndrome (MDS)-contribution to better understanding of MDS.Molecular genetic study showing that the IN/157 'oligodendroglioma' cell line has been contaminated by rhabdomyosarcoma (RD) cells.Laboratory probing of oncogenes from human liquid and solid specimens as markers of exposure to toxicants.Production of fibronectin and adherence to fibronectin by human myeloma cell lines.Establishment and characterization of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome.Analysis of methylation in the c-MYC gene in five human myeloma cell lines.Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.Cytochemical and molecular properties of simian virus 40 transformed Kaposi's sarcoma-derived cells: evidence for the secretion of a member of the fibroblast growth factor family.Mutations of N-ras oncogene in myelodysplastic syndromes and leukemias detected by polymerase chain reaction.Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteinsHigh frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.N-RAS mutations in T-cell acute lymphocytic leukaemia: analysis by direct sequencing detects a novel mutation.
P2860
Q24643802-3777282C-0B7B-4EC8-9E23-833E00DA57C0Q28217097-424F327F-6506-42FF-9B0C-6B7FB84A92F4Q33335103-DECD5A95-1D40-40DB-BC34-38640B768A5DQ33558078-D9C68D87-8887-46D2-A815-DDEB3002B97DQ33560907-DF6527D9-87FB-4EA5-B2AB-E8A585317838Q34066655-D155A7A2-ACFD-4341-8E5F-86B63CF7015BQ34125947-04EAC916-515C-4A42-898C-3E08DE6469EFQ34298327-64F8BDD5-3E5C-459A-9436-2D30335D05AAQ34381096-10C59EE5-9019-4EE1-8698-EF31122CD189Q34844276-9E9B0424-3516-486A-884E-DA51F7FED078Q35010156-1554A7E8-A333-45E2-9C90-4559DE6616A8Q35103708-7095E200-8739-4A4E-B65C-8977E32C938BQ35787871-829DD6CE-BA14-4B15-ADD1-8A028DB00050Q35831077-03F8684F-7B4F-4545-B1EC-8988C85D3F28Q36362104-921E49DE-F9F7-4172-BA71-1FC534013A51Q36766981-A30D7ABA-DD25-408D-B5EE-C64314A2C7C6Q37407161-EC2DDD7B-612A-4029-AE55-029EF0DD1F62Q37875000-0FC48E0F-EAA0-49EA-806F-CAC2437A201BQ38122703-81CE8BA9-ED8B-460A-A358-0C805D656524Q38334981-1FD6F8AD-1C9E-468C-9CE9-81D23C87CD5FQ38602666-E4D5F7D8-A958-42DB-93D9-59DE5E9FC64EQ38675318-B7BF9EF5-578E-45DC-BEFE-D7E9B0521BEFQ40116867-273B2505-901A-4D8F-8986-DD09EFF1759AQ40318729-3240CCE3-2646-43F6-A1CE-C27608F248E2Q40493952-2C1670E5-6C9A-43BA-8E34-34DFB4F0FB38Q40624830-275BA070-D14F-46AA-81E7-C06F5933B533Q40646616-D1FDB187-268B-4E01-A2CF-598EA6CD059BQ40722937-B569A758-E313-4B96-B1B5-56E080E6B1EBQ40958116-3B362C7B-80F6-4920-B326-7076F9E651C6Q41119699-BDBFA35C-07B0-45A7-BBEA-25A3C6D0B075Q41188296-C0B7B015-2D0A-483F-B087-F44AF90844B2Q41465157-2B33BEDC-4CB8-4AF7-A06F-6A26D644B700Q41465166-EAF8DFB4-65B2-41CE-8A9E-300CC5A4288AQ41696394-333BB66F-E95A-476A-A85F-21DEC3D0FE5BQ41755821-7EBF56C5-CF58-4FA3-A5E8-2F2414ED5C16Q41760163-91C4DB99-0BFA-46F4-BAAD-0CCF1AAB0F15Q42117822-12A91DC9-3B8F-4910-817F-4680BAB68CD8Q42767811-6BC57A66-C026-4961-92F9-3D89C241B9F8Q42800278-A69AB474-CF2F-4A6F-B0EE-212043EF6EB8Q45970339-F9A1E265-01BF-4996-8602-82552746BF92
P2860
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
@ast
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
@en
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
@nl
type
label
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
@ast
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
@en
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
@nl
prefLabel
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
@ast
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
@en
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
@nl
P2093
P356
P1433
P1476
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
@en
P2093
H Mizoguchi
K Hagiwara
P2888
P356
10.1038/327430A0
P407
P577
1987-06-01T00:00:00Z
P6179
1001277011